Takeda is said to be considering the sale of assets in emerging markets and western Europe to pay down some of the debt it has taken on with the $62 billion acquisition of Shire.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,